KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogenomics (NEO) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Neogenomics (NEO) over the last 17 years, with Q3 2025 value amounting to -$0.21.

  • Neogenomics' EPS (Basic) fell 5000.0% to -$0.21 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.88, marking a year-over-year decrease of 4426.23%. This contributed to the annual value of -$0.62 for FY2024, which is 1120.52% up from last year.
  • As of Q3 2025, Neogenomics' EPS (Basic) stood at -$0.21, which was down 5000.0% from -$0.35 recorded in Q2 2025.
  • In the past 5 years, Neogenomics' EPS (Basic) ranged from a high of $0.64 in Q2 2021 and a low of -$0.4 during Q1 2022
  • Over the past 5 years, Neogenomics' median EPS (Basic) value was -$0.19 (recorded in 2021), while the average stood at -$0.17.
  • Data for Neogenomics' EPS (Basic) shows a peak YoY increase of 116666.67% (in 2021) and a maximum YoY decrease of 95000.0% (in 2021) over the last 5 years.
  • Neogenomics' EPS (Basic) (Quarter) stood at -$0.35 in 2021, then soared by 48.57% to -$0.18 in 2022, then skyrocketed by 38.89% to -$0.11 in 2023, then fell by 9.99% to -$0.12 in 2024, then tumbled by 73.57% to -$0.21 in 2025.
  • Its last three reported values are -$0.21 in Q3 2025, -$0.35 for Q2 2025, and -$0.2 during Q1 2025.